MétaCan
Menu
Back to cohort
Record W4416566577 · doi:10.1016/j.drugpo.2025.105070

A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda

2025· article· en· W4416566577 on OpenAlexafffundabout
Uyen Do, Sarah Larney, Matthew Bonn, Ingrid Matei, Camille Zolopa, Amy Bergeron, Mohammad Karamouzian, Elaine Hyshka, Thomas D. Brothers, Nikki Bozinoff, Dan Werb, Didier Jutras‐Aswad, Stine Bordier Høj, Igor Yakovenko, Julie Bruneau

Bibliographic record

VenueInternational Journal of Drug Policy · 2025
Typearticle
Languageen
FieldMedicine
TopicOpioid Use Disorder Treatment
Canadian institutionsCentre for Addiction and Mental HealthDalhousie UniversityPublic Health OntarioAtlantic School of TheologySt. Michael's HospitalUniversity of AlbertaUniversité de MontréalMcGill UniversityCentre Hospitalier de l’Université de Montréal
FundersFonds de Recherche du Québec - SantéCanadian Institutes of Health ResearchHealth CanadaDalhousie UniversityFonds de recherche du QuébecSt. Michael's Hospital Foundation
KeywordsSAFERPsychological interventionSupply chainFormal concept analysisOpioidMEDLINEOpioid-Related Disorders

Abstract

fetched live from OpenAlex

• “Safe(r) supply” lumps various approaches together; yet, approaches range widely from prescription-based (medicalized) to non-prescription-based (non-medicalized). • Medicalized and non-medicalized approaches share a core harm-reduction intent but differ in their underlying philosophies, key characteristics, and potential benefits and harms. • Standardized terminology is recommended, transitioning away from using the language of “safer supply” in reference to medical models and adopting the terminology of “prescribed opioid alternative interventions” to reflect the range models of care situated along the continuum from harm reduction to treatment. • Systematic data collection, standardized documentation, and robust evaluation are needed. Providing pharmaceutical opioid medications as alternatives to the unregulated drug market, commonly referred to as safe supply or safer supply (hereafter “safe(r) supply”), has emerged as a harm reduction strategy in Canada, with wide variation in principles and implementation. We aimed to clarify the concept of safe(r) opioid supply across harm-reduction and clinical contexts. We conducted a scoping review and concept analysis. We systematically searched six major electronic databases and the grey literature to identify articles published between 2010 and 2024. Informed by Walker and Avant’s concept analysis methodology, we extracted definitions and descriptions of programs and interventions, organizing key characteristics into thematic dimensions to develop a framework distinguishing various care approaches. Our review included 95 articles. Safe(r) supply operationalizes under two broad approaches: a medicalized/prescribed approach (‘safer supply’) and a non-medicalized/community-based approach (‘safe supply’). We outlined three illustrative cases that nest within these approaches: (1) Prescribed opioids with opioid agonist therapy (OAT) offered and/or co-prescribed, (2) Prescribed opioids without OAT, (3) Community-based distribution of unregulated drugs with known composition. Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced understanding is crucial for developing evidence-based strategies in response to Canada’s drug poisoning crisis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.144
metaresearch head score (Gemma)0.265
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.925
Threshold uncertainty score0.764

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1440.265
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0080.008
Bibliometrics0.0990.082
Science and technology studies0.0070.007
Scholarly communication0.0160.017
Open science0.0070.010
Research integrity0.0070.005
Insufficient payload (model declined to judge)0.0100.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.437
Teacher spread0.409 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueInternational Journal of Drug PolicySame topicOpioid Use Disorder TreatmentFrench-language works237,207